莫尔加尼白内障:临床特征、手术管理与结局
美国一家三级学术转诊中心回顾性分析50例莫尔加尼白内障成人患者,术前86%视力为手动或更差,48%存在晶状体诱导性眼压升高,42%存在悬韧带薄弱。40眼接受手术,35%发生术中并发症,术后平均BCVA从2.39 logMAR改善至0.68 logMAR(P<0.001),50%术眼BCVA达20/40或更好,术后1月平均眼压从26.0 mmHg降至16.7 mmHg(P=0.003)。
要点
- 莫尔加尼白内障常伴严重视力丧失、晶状体诱导性眼压升高和悬韧带薄弱。
- 手术并发症风险高,40眼中14眼(35%)发生术中并发症。
- 术后半数术眼BCVA达20/40或更好,眼压下降但许多眼仍需降眼压药物。
核心结论
- 莫尔加尼白内障与严重视力丧失、压力相关并发症和悬韧带薄弱相关,术中风险较高。
- 尽管复杂,半数手术眼最终BCVA达20/40或更好,术后眼压下降但许多眼仍需继续药物治疗。
- 结果支持仔细术前评估、就囊膜和悬韧带并发症及备选IOL固定方式进行沟通,并制定个体化手术策略。
研究设计与样本
- 回顾病历收集人口学特征、眼部表现、影像学、手术管理、术中并发症、IOL固定、术后并发症、BCVA和IOP。
主要发现
- 术前BCVA为手动或更差者43/50眼(86%),平均术前IOP为25.8 ± 16.2 mmHg。
- 晶状体诱导性IOP升高24/50眼(48%),晶状体诱导性青光眼19/50眼(38%),悬韧带薄弱18/43眼(42%)。
- 40/50眼(80%)接受手术,其中初试超声乳化30/40眼(75%),手动小切口白内障手术5/40眼(13%),平坦部晶状体切除联合玻璃体切除5/40眼(13%)。
- 术中并发症14/40眼(35%),包括后囊膜破裂8/40眼(20%);总体16/40眼(40%)获得囊袋内IOL。
- 平均BCVA从术前2.39 ± 0.58 logMAR改善至末次随访0.68 ± 0.81 logMAR(配对分析;P < 0.001),20/40眼(50%)达到20/40或更好。
关键数值与推荐
- 莫尔加尼白内障术前BCVA手动或更差占86%(43/50眼),平均IOP 25.8 ± 16.2 mmHg。
- 晶状体诱导性IOP升高占48%(24/50眼),晶状体诱导性青光眼占38%(19/50眼),悬韧带薄弱占42%(18/43眼)。
- 术中并发症占35%(14/40眼),后囊膜破裂占20%(8/40眼),囊袋内IOL占40%(16/40眼)。
- 术后BCVA达20/40或更好占50%(20/40眼),平均BCVA从2.39 ± 0.58 logMAR改善至0.68 ± 0.81 logMAR(P < 0.001)。
- 术后1月平均IOP从26.0 ± 16.9 mmHg降至16.7 ± 5.5 mmHg(P = 0.003),50%(20/40眼)仍需降眼压药物。
临床怎么用
- 对莫尔加尼白内障应仔细术前评估,关注晶状体诱导性眼压升高和悬韧带薄弱。
- 术前沟通应涵盖囊膜和悬韧带并发症风险及备选IOL固定方式。
- 根据悬韧带状态和术中情况制定个体化手术策略。
局限性
- 回顾性设计限制解释。
- 样本量适中且随访不一致。
- 三级转诊中心设置可能限制结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the clinical features, surgical management, and outcomes of Morgagnian cataracts. DESIGN: Retrospective clinical cohort study. SUBJECTS: Fifty eyes of 50 adults diagnosed with Morgagnian cataracts at a tertiary academic referral center in the United States from October 2015 through August 2026. METHODS: Medical records were reviewed for demographic characteristics, ocular findings, imaging, surgical management, intraoperative complications, intraocular lens (IOL) fixation, postoperative complications, best-corrected visual acuity (BCVA), and intraocular pressure (IOP). MAIN OUTCOME MEASURES: Surgical management, intraoperative complications, postoperative BCVA, and IOP. RESULTS: Presenting BCVA was hand motions or worse in 43/50 eyes (86%). Mean presenting IOP was 25.8 ± 16.2 mmHg. Lens-induced IOP elevation was present in 24/50 eyes (48%), lens-induced glaucoma in 19/50 (38%), and zonular weakness in 18/43 (42%). Surgery was performed in 40/50 eyes (80%). Phacoemulsification was initially attempted in 30/40 eyes (75%), manual small-incision cataract surgery in 5/40 (13%), and pars plana lensectomy with vitrectomy in 5/40 (13%). Intraoperative complications occurred in 14/40 eyes (35%), including posterior capsule rupture in 8/40 (20%); overall, 16/40 eyes (40%) received an in-the-bag IOL. Mean BCVA improved from 2.39 ± 0.58 logMAR preoperatively to 0.68 ± 0.81 logMAR at the last follow-up (paired analysis; P < 0.001), with 20/40 eyes (50%) achieving 20/40 or better. Mean IOP decreased from 26.0 ± 16.9 mmHg at presentation to 16.7 ± 5.5 mmHg at postoperative month 1 (P = 0.003), although 20/40 eyes (50%) remained on IOP-lowering medications. CONCLUSIONS: Morgagnian cataracts were associated with profound visual loss, pressure-related complications, and zonular weakness, with substantial intraoperative risk. Despite this complexity, half of the operated eyes achieved BCVA of 20/40 or better. IOP decreased after cataract extraction in the setting of continued medical therapy in many eyes. These findings support careful preoperative assessment, counseling regarding capsular and zonular complications and potential alternative IOL fixation, and an individualized surgical strategy. However, the retrospective design, modest sample size, and variable follow-up limit interpretation, while the tertiary referral setting may limit generalizability.
引用
- Kang S, Wallace RT, Gedde SJ, et al. Morgagnian Cataract: Clinical Features, Surgical Management, and Outcomes. Am J Ophthalmol. 2026. PMID: 42918530. doi:10.1016/j.ajo.2026.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。